Sharon Youmans, PharmD, MPH, and UCSF School of Pharmacy vice dean, is the newly elected Council of Deans Secretary, American Association of Colleges of Pharmacy (AACP).
The council includes a select number of the nation’s leaders in academic pharmacy. Council activities focus on educational policies, professional program administration within academic institutions, and the ties between academic pharmacy and the community.
Renowned researcher and educator Matthew Jacobson, PhD, has been named the new chair of the UCSF School of Pharmacy’s Department of Pharmaceutical Chemistry. His appointment by Dean B. Joseph Guglielmo, PharmD, will be effective January 15, 2016.
Jacobson will become the department’s 10th chair since its formation in 1958. He succeeds James Wells, PhD, who is stepping down from the post after leading the department since 2008.
Andrej Sali, PhD, has been appointed associate dean of research of the UCSF School of Pharmacy, effective July 1, 2015. The appointment is in addition to Sali’s full professorship in the School’s Department of Bioengineering and Therapeutic Sciences. As he continues with his own research, Sali will advise Dean B. Joseph Guglielmo, PharmD, and School leaders on pertinent research issues and opportunities and will represent the School in critical campus research decisions.
School faculty member Esteban G. Burchard, MD, MPH, has been appointed to an expert panel advising the National Institutes of Health (NIH) on how to develop President Barack Obama’s Precision Medicine Initiative.
The $215 million initiative, announced by Obama earlier this year, aims to gather and analyze vast amounts of genetic and other patient data to develop more targeted, personalized therapies for treating disease.
The most recently hired faculty members to join the UCSF School of Pharmacy have research interests that range from the treatment of blood clots to mapping biological networks in cancer cells to understanding the molecular workings of ion channels in cell membranes. But they all share the common purpose of ultimately discovering new ways to better address disease through therapeutics. These eight are now at work in the School’s three departments.
Tejal Desai, PhD, has been named the new chair of the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department of the UCSF Schools of Pharmacy and Medicine. Her appointment is effective August 1, 2014.
University of California President Janet Napolitano has announced that her choice for the 10th chancellor of UC San Francisco is Sam Hawgood, MBBS, the UCSF School of Medicine dean who has served as interim UCSF chancellor since April 1. The UC Board of Regents will vote on Napolitano’s selection and the terms of the appointment on July 17.
President Napolitano Selects Sam Hawgood as Next Chancellor of UC San Francisco – UCSF
The U.S. Food and Drug Administration (FDA) is tapping the UCSF School of Pharmacy and Stanford University to launch its first West Coast regulatory science center, focused on spurring innovation in the development and evaluation of safer and more effective medications.
The UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (CERSI) has been formally launched with an initial FDA grant of $3.3 million.
Joseph Guglielmo, PharmD, an honored UCSF professor and mentor as well as a leading pharmacist and clinical scientist specializing in antimicrobial therapies, will be the new dean of the UCSF School of Pharmacy.
His appointment, officially announced today by UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, after being approved by UC President Mark Yudof, will take effect April 1.